Despite Pfizer’s announcement in January to end its research for treatment of dementia, investments made this year in dementia R&D, particularly Alzheimer’s, a form of dementia, highlight the call for new investments for research to investigate and treat the syndrome. An estimated 50 million individuals suffer from dementia worldwide, according to the World Health Organization. The […]

The chemical industry accounted for 4%, or an estimated $2.2 billion, in sales of analytical instruments and laboratory products in 2017. As a result, chemical industry spending is an important component of the overall instrument market’s growth. Applications for analytical testing of chemical constituents and end-products include R&D and QA/QC. In Germany, the world’s third […]

Earlier this month, the National Science and Technology Council’s Subcommittee on Nanoscale Science, Engineering and Technology released the National Nanotechnology Initiative (NNI) supplement to the proposed fiscal 2019 US federal budget. The report identifies budget information and agency plans to accelerate the growth of nanotechnological R&D in the US. Established in 2001 and formally authorized […]

At the mid-point of 2018, changes in R&D spending by the world’s largest biopharmaceutical companies is a mixed bag, negatively affected by one-time events and currency. The table below shows the first-half 2018 R&D spending for the world’s top 10 biopharmaceutical companies, according to Evaluate. For three companies, R&D changes are expected as new executives […]

Genetically modified foods have been on the market for decades, but recent innovations in gene editing are opening the door to new frontiers and opportunities. These newer gene-editing techniques boast accuracy, speed and affordability, and companies are aiming to dispel the negative connotations of genetically modified foods and decrease the regulatory obstacles that can limit […]

Register for Free Trial Login for Access

Register for Free Trial Login for Access

Lost your password? Register